Luneri

L Theanine clinical brief

L Theanine

Dossier liveA

Cognitive

CognitiveDossier-backed

Compare alternatives

Evidence strength

High confidence

4 meta-analyses - 73 RCTs - 107 tracked studies

What it is for

Acute stress response / anxiolytic

The clearest current human use case based on dose, outcomes, and clinical coverage.

What moves

Highest-signal biomarkers

Human linked

HbA1c

Glycemic control

No Effect

Grade B

Lipid response

No Effect

Grade B

LDL-C

Lipid response

No Effect

Grade B

Research signal

Top caution

Drug interaction

Additive GABAergic potentiation: L-theanine increases GABA synthesis and release via glutamate-to-GABA shunting; co-administration may augment CNS depression, sedation, and psychomotor impairment

Evidence index

Authored product-registry confidence score

Meta-analyses

Pooled human evidence

RCTs

Randomized clinical trials

Tracked studies

107

Studies currently mapped to this dossier

Clinical memoHigh confidence

Executive summary

Immediate brief

L Theanine is a Cognitive with its clearest current use in Acute stress response / anxiolytic.

High confidence human evidence supports the brief, anchored by 107 tracked studies, 4 meta-analyses, 73 RCTs and the most reliable movement in HbA1c, TC, LDL-C.

L-theanine generally well-tolerated at standard doses in enriched RCTs Additive GABAergic potentiation: L-theanine increases GABA synthesis and release via glutamate-to-GABA shunting; co-administration may augment CNS depression, sedation, and psychomotor impairment Clinical trials measuring BP and HR as theanine endpoints must include standardized stress induction protocols; resting-state cardiovascular measurements are not valid efficacy endpoints for L-theanine

Anchor decision

Acute stress response / anxiolytic

Best current human use case

Confidence

High confidence

4 meta-analyses - 73 RCTs - 107 tracked studies

How to use this brief

1. Orient

Use the overview tab to understand mechanism, safety, scope, and where the current evidence still has blind spots.

2. Pressure-test

Move into evidence and biomarkers once the memo already makes sense, so the tables confirm or challenge the narrative rather than replace it.

3. Operationalize

Finish with dosing and PGx when the compound still looks useful and you are deciding whether it belongs in a real protocol.

L TheanineDossier liveAPrimary useAcute stress response / anxiolytic

CautionDrug interaction

Major warning

Pregnancy

Clinical trials measuring BP and HR as theanine endpoints must include standardized stress induction protocols; resting-state cardiovascular measurements are not valid efficacy endpoints for L-theanine

Overview

Clinical posture

Start with mechanism and safety, then move into scope, synergies, and the open questions that still matter before going deeper into tables.

Primary signal

Mechanism summary

Read this as the shortest defensible explanation for why the compound belongs in the conversation at all.

Glutamate receptor antagonism - L-theanine binds AMPA, kainate, and partially antagonizes NMDA glutamate receptor subtypes, inhibiting excitatory neurotransmission; structurally analogous to glutamate and inhibits glutamine re-uptake at pre-synapse, reducing glutamate pool replenishment

Alpha-band EEG oscillation enhancement - L-theanine selectively increases occipital and parietal alpha (8-12 Hz) power at rest, consistent with a relaxed-alert state without sedation; effect observed within 30-60 min of oral ingestion

HPA axis attenuation - L-theanine reduces salivary cortisol and alpha-amylase in response to psychosocial stressors, indicating modulation of hypothalamic-pituitary-adrenal and sympathoadrenal stress reactivity

Sympathetic nervous system attenuation - L-theanine blunts stress-induced heart rate and blood pressure elevation, consistent with reduced catecholaminergic sympathetic output; effect is stress-context dependent and not observed at resting baseline

Co-primary

Safety summary

These are the reasons this compound can still break trust if the protocol fit is otherwise attractive.

L-theanine generally well-tolerated at standard doses in enriched RCTs

Additive GABAergic potentiation: L-theanine increases GABA synthesis and release via glutamate-to-GABA shunting; co-administration may augment CNS depression, sedation, and psychomotor impairment

Supporting context

Evidence scope

Read these caveats before assuming the effect sizes generalize cleanly across every population or use case.

Evidence scope

Review

Evidence scope

Review

Study designs incorporating L-theanine in functional food products require bioavailability verification; do not extrapolate efficacy from capsule studies to food matrix products without independent PK/PD validation

Evidence scope

Review

Exclude green tea mixture studies from pure L-theanine biomarker claims; flag clearly in UI as 'green tea (mixed compound)' rather than L-theanine-specific evidence

Evidence scope

Review

When applying green tea/theanine evidence to clinical recommendations, note that studies were conducted in habitual consumers; effects may be larger in non-consumers

Synergies

Potential pairing logic is useful only when it adds a cleaner decision path, not when it becomes an excuse to stack indiscriminately.

L Theanine + gaba

DDeclared

Animal data only - grade D.

Research unknowns

These are the open questions that still keep the compound from reading like a closed case.

What is the direct receptor-level mechanism by which L-theanine promotes alpha-band EEG oscillations? Is this mediated primarily through glutamate receptor antagonism, GABAergic enhancement, or thalamocortical circuit modulation?

Does L-theanine efficacy for anxiety and sleep outcomes differ between East Asian and Western populations, controlling for habitual tea intake, dietary glutamate exposure, and LAT1 polymorphism frequency?

What are the pharmacokinetics and safety of L-theanine in children under 12, particularly in neurodevelopmental conditions (ADHD, ASD) where glutamatergic/GABAergic modulation is mechanistically relevant?

Does chronic L-theanine supplementation (>12 weeks) at standard doses (200-400mg/day) produce any hepatic, renal, or hematologic changes in healthy adults?